Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study is a semi-experimental clinical trial that 20 patients (40 eyes) with PDR underwent PRP with ARC with a spot number of 1,200 to 1,500 per eye and spot size 500 micron with a duration of 200 ms. The variables of contrast sensitivity, macula thickness under fovea , BCVA, the width of thyroid under fovea , RNFL thickness in the four areas around the disc, and the quality of life questionnaire of all patients were recorded at the beginning of the study.Retinal and choroid under fovea thickness and RNFL thickness were assessed in four areas, one week and one month after the end of treatment, and all the variables mentioned earlier were evaluated three months after PRP surgery.
This study is single group that the outcomes are compared before and after the intervention
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group | Experimental | 20 patients (40 eyes) with PDR underwent PRP with ARC with a spot number of 1,200 to 1,500 per eye and spot size 500 micron with a duration of 200 ms. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Panretinal Photocoagulation (PRP) | Procedure | PRP with ARC with a spot number of 1,200 to 1,500 per eye and spot size 500 micron with a duration of 200 ms. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Life Quality | A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease Which is measured by a quality of life questionnaire | up to 3 months |
| RNFL | retinal nerve fiber layer which measured by PP-OCT (optical coherence tomography) | up to 30 days |
| BCVA | best corrected visual acuity which measured by SD-OCT | up to 3 months |
| Retinal thickness in the central part of Fovea | Measured by SD-OCT | up to 30 days |
| Choroid thickness in the central part of Fovea | Measured by EDI-OCT | up to 30 days |
| Physical examination of PDR | An eye exam performed by an ophthalmologist will determine if there is retinopathy | up to 3 months |
| Contrast sensitivity | Contrast sensitivity which measured by Melbourne edge test | up to 3 months |
| Angiography with fluorescein | By injecting fluorescein into the vein and then taking an X-ray to diagnose PDR |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mohammad Sadegh Bagheri Baghdasht | Tehran | 0 | Iran |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| up to 3 months |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided